List of Tables
Table 1. Global Respiratory Disease Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Respiratory Disease Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Respiratory Disease Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Respiratory Disease Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Respiratory Disease Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Respiratory Disease Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Respiratory Disease Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Respiratory Disease Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Respiratory Disease Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Respiratory Disease Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Respiratory Disease Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Respiratory Disease Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Respiratory Disease Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Respiratory Disease Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Respiratory Disease Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Respiratory Disease Vaccine Sales by Region (K Units), 2021–2026
Table 18. Global Respiratory Disease Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Respiratory Disease Vaccine Sales by Region (K Units), 2027–2032
Table 20. Global Respiratory Disease Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Respiratory Disease Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Respiratory Disease Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Respiratory Disease Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Respiratory Disease Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Respiratory Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Respiratory Disease Vaccine Sales by Country (K Units), 2021–2026
Table 27. North America Respiratory Disease Vaccine Sales by Country (K Units), 2027–2032
Table 28. North America Respiratory Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Respiratory Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Respiratory Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Respiratory Disease Vaccine Sales by Country (K Units), 2021–2026
Table 32. Europe Respiratory Disease Vaccine Sales by Country (K Units), 2027–2032
Table 33. Europe Respiratory Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Respiratory Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Respiratory Disease Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Respiratory Disease Vaccine Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Respiratory Disease Vaccine Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Respiratory Disease Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Respiratory Disease Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Respiratory Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Respiratory Disease Vaccine Sales by Country (K Units), 2021–2026
Table 42. Latin America Respiratory Disease Vaccine Sales by Country (K Units), 2027–2032
Table 43. Latin America Respiratory Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Respiratory Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Respiratory Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Respiratory Disease Vaccine Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Respiratory Disease Vaccine Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Respiratory Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Respiratory Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Respiratory Disease Vaccine Sales (K Units) by Type (2021–2026)
Table 51. Global Respiratory Disease Vaccine Sales (K Units) by Type (2027–2032)
Table 52. Global Respiratory Disease Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Respiratory Disease Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Respiratory Disease Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Respiratory Disease Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Respiratory Disease Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Respiratory Disease Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Respiratory Disease Vaccine Price (US$/Unit) by Type (2021–2026)
Table 59. Global Respiratory Disease Vaccine Price (US$/Unit) by Type (2027–2032)
Table 60. Global Respiratory Disease Vaccine Sales (K Units) by Application (2021–2026)
Table 61. Global Respiratory Disease Vaccine Sales (K Units) by Application (2027–2032)
Table 62. Global Respiratory Disease Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Respiratory Disease Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Respiratory Disease Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Respiratory Disease Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Respiratory Disease Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Respiratory Disease Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Respiratory Disease Vaccine Price (US$/Unit) by Application (2021–2026)
Table 69. Global Respiratory Disease Vaccine Price (US$/Unit) by Application (2027–2032)
Table 70. AstraZeneca Company Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. AstraZeneca Respiratory Disease Vaccine Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Emergent BioSolutions Inc. Company Information
Table 76. Emergent BioSolutions Inc. Description and Business Overview
Table 77. Emergent BioSolutions Inc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Emergent BioSolutions Inc. Respiratory Disease Vaccine Product
Table 79. Emergent BioSolutions Inc. Recent Developments/Updates
Table 80. GSK plc. Company Information
Table 81. GSK plc. Description and Business Overview
Table 82. GSK plc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. GSK plc. Respiratory Disease Vaccine Product
Table 84. GSK plc. Recent Developments/Updates
Table 85. Johnson & Johnson Services, Inc. Company Information
Table 86. Johnson & Johnson Services, Inc. Description and Business Overview
Table 87. Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Product
Table 89. Johnson & Johnson Services, Inc. Recent Developments/Updates
Table 90. Merck & Co., Inc. Company Information
Table 91. Merck & Co., Inc. Description and Business Overview
Table 92. Merck & Co., Inc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Merck & Co., Inc. Respiratory Disease Vaccine Product
Table 94. Merck & Co., Inc. Recent Developments/Updates
Table 95. Novavax Company Information
Table 96. Novavax Description and Business Overview
Table 97. Novavax Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Novavax Respiratory Disease Vaccine Product
Table 99. Novavax Recent Developments/Updates
Table 100. Pfizer Inc. Company Information
Table 101. Pfizer Inc. Description and Business Overview
Table 102. Pfizer Inc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Pfizer Inc. Respiratory Disease Vaccine Product
Table 104. Pfizer Inc. Recent Developments/Updates
Table 105. Sanofi SA Company Information
Table 106. Sanofi SA Description and Business Overview
Table 107. Sanofi SA Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Sanofi SA Respiratory Disease Vaccine Product
Table 109. Sanofi SA Recent Developments/Updates
Table 110. Serum Institute of India Pvt. Ltd. Company Information
Table 111. Serum Institute of India Pvt. Ltd. Description and Business Overview
Table 112. Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Product
Table 114. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 115. SINOVAC Company Information
Table 116. SINOVAC Description and Business Overview
Table 117. SINOVAC Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. SINOVAC Respiratory Disease Vaccine Product
Table 119. SINOVAC Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Respiratory Disease Vaccine Distributors List
Table 123. Respiratory Disease Vaccine Customers List
Table 124. Respiratory Disease Vaccine Market Trends
Table 125. Respiratory Disease Vaccine Market Drivers
Table 126. Respiratory Disease Vaccine Market Challenges
Table 127. Respiratory Disease Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Respiratory Disease Vaccine
Figure 2. Global Respiratory Disease Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Respiratory Disease Vaccine Market Share by Type: 2025 & 2032
Figure 4. Live Attenuated Product Picture
Figure 5. Inactivated Product Picture
Figure 6. Others Product Picture
Figure 7. Global Respiratory Disease Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Respiratory Disease Vaccine Market Share by Application: 2025 & 2032
Figure 9. Flu
Figure 10. Pneumonia
Figure 11. Others
Figure 12. Global Respiratory Disease Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Respiratory Disease Vaccine Market Size (US$ Million), 2021–2032
Figure 14. Global Respiratory Disease Vaccine Sales (K Units), 2021–2032
Figure 15. Global Respiratory Disease Vaccine Average Price (US$/Unit), 2021–2032
Figure 16. Respiratory Disease Vaccine Report Years Considered
Figure 17. Respiratory Disease Vaccine Sales Share by Manufacturers in 2025
Figure 18. Global Respiratory Disease Vaccine Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Respiratory Disease Vaccine Players: Market Share by Revenue in Respiratory Disease Vaccine in 2025
Figure 20. Respiratory Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Respiratory Disease Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Respiratory Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 23. North America Respiratory Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 24. United States Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Respiratory Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 27. Europe Respiratory Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 28. Germany Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Respiratory Disease Vaccine Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Respiratory Disease Vaccine Revenue Market Share by Region (2021–2032)
Figure 35. China Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Respiratory Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 43. Latin America Respiratory Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Respiratory Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Respiratory Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Respiratory Disease Vaccine by Type (2021–2032)
Figure 54. Global Revenue Market Share of Respiratory Disease Vaccine by Type (2021–2032)
Figure 55. Global Respiratory Disease Vaccine Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Respiratory Disease Vaccine by Application (2021–2032)
Figure 57. Global Revenue Market Share of Respiratory Disease Vaccine by Application (2021–2032)
Figure 58. Global Respiratory Disease Vaccine Price (US$/Unit) by Application (2021–2032)
Figure 59. Respiratory Disease Vaccine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
